Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Role of next generation sequencing in diagnosis and management of critically ill children with suspected monogenic disorder

European Journal of Human Genetics volume 32, pages 1106–1115 (2024)Cite this article

Subjects

Abstract

Next generation sequencing based diagnosis has emerged as a promising tool for evaluating critically ill neonates and children. However, there is limited data on its utility in developing countries. We assessed its diagnostic rate and clinical impact on management of pediatric patients with a suspected genetic disorder requiring critical care. The study was conducted at a single tertiary hospital in Northern India. We analyzed 70 children with an illness requiring intensive care and obtained a precise molecular diagnosis in 32 of 70 probands (45.3%) using diverse sequencing techniques such as clinical exome, whole exome, and whole genome. A significant change in clinical outcome was observed in 13 of 32 (40.6%) diagnosed probands with a change in medication in 11 subjects and redirection to palliative care in two subjects. Additional benefits included specific dietary management (three cases), avoidance of a major procedure (one case) and better reproductive counseling. Dramatic therapeutic responses were observed in three cases with SCN1A, SCN2A and KCNQ2-related epileptic encephalopathy. A delayed turn-around for sequencing results was perceived as a major limiting factor in the study, as rapid and ultra-rapid sequencing was not available. Achieving a precise molecular diagnosis has great utility in managing critically ill patients with suspected genetic disorders in developing countries.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: NGS diagnostic yield as per patient phenotype and dataset analysis.
Fig. 2: Impact of diagnosis by NGS on outcome of 32 diagnosed cases.

Similar content being viewed by others

Data availability

The authors confirm that the data supporting the findings of the study are available within the article and its Supplementary Material. Raw data files will be made available on reasonable request.

References

  1. Yang Y, Muzny DM, Reid JG, Bainbridge MN, Willis A, Ward PA, et al. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N Engl J Med. 2013;369:1502–11. https://doi.org/10.1056/NEJMoa1306555.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Borghesi A, Mencarelli MA, Memo L, Ferrero GB, Bartuli A, Genuardi M, et al. Intersociety policy statement on the use of whole-exome sequencing in the critically ill newborn infant. Ital J Pediatr. 2017;43:100. https://doi.org/10.1186/s13052-017-0418-0.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Soden SE, Saunders CJ, Willig LK, Farrow EG, Smith LD, Petrikin JE, et al. Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders. Sci Transl Med. 2014;6:265. https://doi.org/10.1126/scitranslmed.3010076.

    Article  CAS  Google Scholar 

  4. Kingsmore SF, Dinwiddie DL, Miller NA, Soden SE, Saunders CJ. Adopting orphans: comprehensive genetic testing of Mendelian diseases of childhood by next-generation sequencing. Expert Rev Mol Diagn. 2011;11:855–68. https://doi.org/10.1586/erm.11.70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Freed AS, Clowes Candadai SV, Sikes MC, Thies J, Byers HM, Dines JN, et al. The impact of rapid exome sequencing on medical management of critically ill children. J Pediatr. 2020;226:202–12.e1. https://doi.org/10.1016/j.jpeds.2020.06.020.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24. https://doi.org/10.1038/gim.2015.30.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Landrum MJ, Chitipiralla S, Brown GR, Chen C, Gu B, Hart J, et al. ClinVar: improvements to accessing data. Nucleic Acids Res. 2020;48:D835–44. https://doi.org/10.1093/nar/gkz972.

    Article  CAS  PubMed  Google Scholar 

  8. Green RC, Berg JS, Grody WW, Kalia SS, Korf BR, Martin CL, et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med. 2013;15:565–74. https://doi.org/10.1038/gim.2013.73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Willig LK, Petrikin JE, Smith LD, Saunders CJ, Thiffault I, Miller NA, et al. Whole-genome sequencing for identification of Mendelian disorders in critically ill infants: a retrospective analysis of diagnostic and clinical findings. Lancet Respir Med. 2015;3:377–87. https://doi.org/10.1016/S2213-2600(15)00139-3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Daoud H, Luco SM, Li R, Bareke E, Beaulieu C, Jarinova O, et al. Next-generation sequencing for diagnosis of rare diseases in the neonatal intensive care unit. CMAJ. 2016;188:E254–60. https://doi.org/10.1503/cmaj.150823.

    Article  PubMed  PubMed Central  Google Scholar 

  11. van Diemen CC, Kerstjens-Frederikse WS, Bergman KA, de Koning TJ, Sikkema-Raddatz B, van der Velde JK, et al. Rapid targeted genomics in critically ill newborns. Pediatrics. 2017;140:e20162854. https://doi.org/10.1542/peds.2016-2854.

    Article  PubMed  Google Scholar 

  12. Meng L, Pammi M, Saronwala A, Magoulas P, Ghazi AR, Vetrini F, et al. Use of exome sequencing for infants in intensive care units: ascertainment of severe single-gene disorders and effect on medical management. JAMA Pediatr. 2017;171:e173438. https://doi.org/10.1001/jamapediatrics.2017.3438.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Stark Z, Lunke S, Brett GR, Tan NB, Stapleton R, Kumble S, et al. Meeting the challenges of implementing rapid genomic testing in acute pediatric care. Genet Med. 2018;20:1554–63. https://doi.org/10.1038/gim.2018.37.

    Article  PubMed  Google Scholar 

  14. Petrikin JE, Cakici JA, Clark MM, Willig LK, Sweeney NM, Farrow EG, et al. The NSIGHT1-randomized controlled trial: rapid whole-genome sequencing for accelerated etiologic diagnosis in critically ill infants. NPJ Genom Med. 2018;3:6. https://doi.org/10.1038/s41525-018-0045-8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Farnaes L, Hildreth A, Sweeney NM, Clark MM, Chowdhury S, Nahas S, et al. Rapid whole-genome sequencing decreases infant morbidity and cost of hospitalization. NPJ Genom Med. 2018;3:10. https://doi.org/10.1038/s41525-018-0049-4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Mestek-Boukhibar L, Clement E, Jones WD, Drury S, Ocaka L, Gagunashvili A, et al. Rapid paediatric sequencing (RaPS): comprehensive real-life workflow for rapid diagnosis of critically ill children. J Med Genet. 2018;55:721–8. https://doi.org/10.1136/jmedgenet-2018-105396.

    Article  CAS  PubMed  Google Scholar 

  17. French CE, Delon I, Dolling H, Sanchis-Juan A, Shamardina O, Mégy K, et al. Whole genome sequencing reveals that genetic conditions are frequent in intensively ill children. Intensive Care Med. 2019;45:627–36. https://doi.org/10.1007/s00134-019-05552-x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Ceyhan-Birsoy O, Murry JB, Machini K, Lebo MS, Yu TW, Fayer S, et al. Interpretation of genomic sequencing results in healthy and ill newborns: results from the BabySeq Project. Am J Hum Genet. 2019;104:76–93. https://doi.org/10.1016/j.ajhg.2018.11.016.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Stark Z, Schofield D, Alam K, Wilson W, Mupfeki N, Macciocca I, et al. Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement. Genet Med. 2017;19:867–74. https://doi.org/10.1038/gim.2016.221.

    Article  PubMed  Google Scholar 

  20. Callahan KP, Mueller R, Flibotte J, Largent EA, Feudtner C. Measures of utility among studies of genomic medicine for critically ill infants: a systematic review. JAMA Netw Open. 2022;5:e2225980. https://doi.org/10.1001/jamanetworkopen.2022.25980.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Malam F, Hartley T, Gillespie MK, Armour CM, Bariciak E, Graham GE, et al. Benchmarking outcomes in the neonatal intensive care unit: cytogenetic and molecular diagnostic rates in a retrospective cohort. Am J Med Genet A. 2017;173:1839–47. https://doi.org/10.1002/ajmg.a.38250.

    Article  PubMed  Google Scholar 

  22. Sanford EF, Clark MM, Farnaes L, Williams MR, Perry JC, Ingulli EG, et al. Rapid whole genome sequencing has clinical utility in children in the PICU. Pediatr Crit Care Med. 2019;20:1007–20. https://doi.org/10.1097/PCC.0000000000002056.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Kingsmore SF, Cakici JA, Clark MM, Gaughran M, Feddock M, Batalov S, et al. A randomized, controlled trial of the analytic and diagnostic performance of singleton and trio, rapid genome and exome sequencing in ill infants. Am J Hum Genet. 2019;105:719–33. https://doi.org/10.1016/j.ajhg.2019.08.009.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Powis Z, Farwell Hagman KD, Speare V, Cain T, Blanco K, Mowlavi LS, et al. Exome sequencing in neonates: diagnostic rates, characteristics, and time to diagnosis. Genet Med. 2018;20:1468–71. https://doi.org/10.1038/gim.2018.11.

    Article  PubMed  Google Scholar 

  25. Yang L, Wei Z, Chen X, Hu L, Peng X, Wang J, et al. Use of medical exome sequencing for identification of underlying genetic defects in NICU: experience in a cohort of 2303 neonates in China. Clin Genet. 2022;101:101–9. https://doi.org/10.1111/cge.14075.

    Article  CAS  PubMed  Google Scholar 

  26. Gubbels CS, VanNoy GE, Madden JA, Copenheaver D, Yang S, Wojcik MH, et al. Prospective, phenotype-driven selection of critically ill neonates for rapid exome sequencing is associated with high diagnostic yield. Genet Med. 2020;22:736–44. https://doi.org/10.1038/s41436-019-0708-6.

    Article  PubMed  Google Scholar 

  27. D’Gama AM, Del Rosario MC, Bresnahan MA, Yu TW, Wojcik MH, Agrawal PB. Integrating rapid exome sequencing into NICU clinical care after a pilot research study. NPJ Genom Med. 2022;7:51. https://doi.org/10.1038/s41525-022-00326-9.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Wells CF, Boursier G, Yauy K, Ruiz-Pallares N, Mechin D, Ruault V, et al. Rapid exome sequencing in critically ill infants: implementation in routine care from French regional hospital’s perspective. Eur J Hum Genet. 2022;30:1076–82. https://doi.org/10.1038/s41431-022-01133-7.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Kingsmore SF. Commentary. Clin Chem. 2020;66:51–2. https://doi.org/10.1093/clinchem.2019.310037.

    Article  PubMed  Google Scholar 

  30. Smith HS, Swint JM, Lalani SR, Yamal JM, de Oliveira Otto MC, Castellanos S, et al. Clinical application of genome and exome sequencing as a diagnostic tool for pediatric patients: a scoping review of the literature. Genet Med. 2019;21:3–16. https://doi.org/10.1038/s41436-018-0024-6.

    Article  CAS  PubMed  Google Scholar 

  31. Sandoval Karamian AG, Mercimek-Andrews S, Mohammad K, Molloy EJ, Chang T, Chau V, et al. Neonatal encephalopathy: etiologies other than hypoxic-ischemic encephalopathy. Semin Fetal Neonatal Med. 2021;26:101272. https://doi.org/10.1016/j.siny.2021.101272.

    Article  CAS  PubMed  Google Scholar 

  32. Aslam S, Strickland T, Molloy EJ. Neonatal encephalopathy: need for recognition of multiple etiologies for optimal management. Front Pediatr. 2019;7:142. https://doi.org/10.3389/fped.2019.00142.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Bick D, Jones M, Taylor SL, Taft RJ, Belmont J. Case for genome sequencing in infants and children with rare, undiagnosed or genetic diseases. J Med Genet. 2019;56:783–91. https://doi.org/10.1136/jmedgenet-2019-106111.

    Article  PubMed  Google Scholar 

  34. Clark MM, Hildreth A, Batalov S, Ding Y, Chowdhury S, Watkins K, et al. Diagnosis of genetic diseases in seriously ill children by rapid whole-genome sequencing and automated phenotyping and interpretation. Sci Transl Med. 2019;11:eaat6177. https://doi.org/10.1126/scitranslmed.aat6177.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Stark Z, Tan TY, Chong B, Brett GR, Yap P, Walsh M, et al. A prospective evaluation of whole-exome sequencing as a first-tier molecular test in infants with suspected monogenic disorders. Genet Med. 2016;18:1090–6. https://doi.org/10.1038/gim.2016.1.

    Article  CAS  PubMed  Google Scholar 

  36. Perenthaler E, Nikoncuk A, Yousefi S, Berdowski WM, Alsagob M, Capo I, et al. Loss of UGP2 in brain leads to a severe epileptic encephalopathy, emphasizing that bi-allelic isoform-specific start-loss mutations of essential genes can cause genetic diseases. Acta Neuropathol. 2020;139:415–42. https://doi.org/10.1007/s00401-019-02109-6.

    Article  CAS  PubMed  Google Scholar 

  37. Clark MM, Stark Z, Farnaes L, Tan TY, White SM, Dimmock D, et al. Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases. NPJ Genom Med. 2018;3:16 https://doi.org/10.1038/s41525-018-0053-8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Australian Genomics Health Alliance Acute Care Flagship, Lunke S, Eggers S, Wilson M, Patel C, Barnett CP, et al. Feasibility of ultra-rapid exome sequencing in critically ill infants and children with suspected monogenic conditions in the Australian Public Health Care System. JAMA. 2020;323:2503–11. https://doi.org/10.1001/jama.2020.7671.

    Article  CAS  Google Scholar 

  39. Lunke S, Bouffler SE, Patel CV, Sandaradura SA, Wilson M, Pinner J, et al. Integrated multi-omics for rapid rare disease diagnosis on a national scale. Nat Med. 2023;29:1681–91. https://doi.org/10.1038/s41591-023-02401-9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Best S, Brown H, Lunke S, Patel C, Pinner J, Barnett CP, et al. Learning from scaling up ultra-rapid genomic testing for critically ill children to a national level. NPJ Genom Med. 2021;6:5. https://doi.org/10.1038/s41525-020-00168-3.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Franck LS, Kriz RM, Rego S, Garman K, Hobbs C, Dimmock D. Implementing rapid whole-genome sequencing in critical care: a qualitative study of facilitators and barriers to new technology adoption. J Pediatr. 2021;237:237–43.e2. https://doi.org/10.1016/j.jpeds.2021.05.045.

    Article  CAS  PubMed  Google Scholar 

  42. Xiao F, Yan K, Tang M, Ji X, Hu L, Yang L, et al. Diagnostic utility of rapid sequencing in critically ill infants: a systematic review and meta-analysis. Expert Rev Mol Diagn. 2022;22:833–40. https://doi.org/10.1080/14737159.2022.2123704.

    Article  CAS  PubMed  Google Scholar 

  43. Kamolvisit W, Phowthongkum P, Boonsimma P, Kuptanon C, Rojnueangnit K, Wattanasirichaigoon D, et al. Rapid exome sequencing as the first-tier investigation for diagnosis of acutely and severely ill children and adults in Thailand. Clin Genet. 2021;100:100–5. https://doi.org/10.1111/cge.13963.

    Article  CAS  PubMed  Google Scholar 

  44. Wilkinson DJC, Barnett C, Savulescu J, Newson AJ. Genomic intensive care: should we perform genome testing in critically ill newborns? Arch Dis Child Fetal Neonatal Ed. 2016;101:F94–8. https://doi.org/10.1136/archdischild-2015-308568.

    Article  PubMed  Google Scholar 

  45. Jeffrey JS, Leathem J, King C, Mefford HC, Ross K, Sadleir LG. Developmental and epileptic encephalopathy: personal utility of a genetic diagnosis for families. Epilepsia Open. 2021;6:149–59. https://doi.org/10.1002/epi4.12458.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Vissers LELM, van Nimwegen KJM, Schieving JH, Kamsteeg EJ, Kleefstra T, Yntema HG, et al. A clinical utility study of exome sequencing versus conventional genetic testing in pediatric neurology. Genet Med. 2017;19:1055–63. https://doi.org/10.1038/gim.2017.1.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We would like to thank all the children and families who agreed to be part of this study.

Funding

The study was performed as part of clinical care without research funds.

Author information

Authors and Affiliations

  1. Institute of Medical Genetics and Genomics, Sir Ganga Ram Hospital, New Delhi, India

    Sameer Bhatia, Swasti Pal, Samarth Kulshrestha, Renu Saxena, Sunita Bijarnia-Mahay, Ishwar Chander Verma & Ratna Dua Puri

  2. Department of Paediatrics, Institute of Child Health, Sir Ganga Ram Hospital, New Delhi, India

    Dhiren Gupta

  3. Department of Neonatology, Institute of Child Health, Sir Ganga Ram Hospital, New Delhi, India

    Arun Soni

Authors
  1. Sameer Bhatia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Swasti Pal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Samarth Kulshrestha
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dhiren Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Arun Soni
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Renu Saxena
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Sunita Bijarnia-Mahay
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ishwar Chander Verma
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Ratna Dua Puri
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All the authors have made substantial contributions to the final manuscript including conception and design; acquisition, analysis or interpretation of data. Each author has participated sufficiently in the work and takes public responsibility for appropriate portions of the content. All the authors agree that they would be accountable for all aspects of the work to ensure that questions related to the integrity or accuracy of any part of the work are appropriately investigated and resolved. SB, ICV and RP made substantial contributions to conception and design. SB, DG, AS, SBM, ICV and RP contributed to acquisition of data. SB, SP, SK and RP contributed to analysis and interpretation of data. SB, SP, ICV and RP contributed in drafting the manuscript and critical revision. All authors approve the final version to be published.

Corresponding author

Correspondence to Ratna Dua Puri.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethical approval

The study was approved by the Institution Ethics Committee (EC/07/18/1384).

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bhatia, S., Pal, S., Kulshrestha, S. et al. Role of next generation sequencing in diagnosis and management of critically ill children with suspected monogenic disorder. Eur J Hum Genet 32, 1106–1115 (2024). https://doi.org/10.1038/s41431-024-01569-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41431-024-01569-z

This article is cited by

Search

Advanced search

Quick links